{"title":"Current Nonsurgical Management of Intermittent Exotropia","authors":"J. Holmes","doi":"10.3368/aoj.66.1.42","DOIUrl":null,"url":null,"abstract":"Three common nonsurgical management strategies for childhood intermittent exotropia are observation alone, part-time patching, and over-minus spectacles. Each of these approaches has support from recent large observational studies and recent randomized clinical trials. The deterioration rate with observation alone is particularly low, over both a 6-month and 2-year period, suggesting that observation alone is a very reasonable option. Future studies on the natural history of childhood intermittent exotropia are forthcoming and a larger randomized clinical trial of over-minus spectacles versus non-over-minus spectacles is planned.","PeriodicalId":76599,"journal":{"name":"The American orthoptic journal","volume":"66 1","pages":"42 - 46"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3368/aoj.66.1.42","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American orthoptic journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3368/aoj.66.1.42","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Three common nonsurgical management strategies for childhood intermittent exotropia are observation alone, part-time patching, and over-minus spectacles. Each of these approaches has support from recent large observational studies and recent randomized clinical trials. The deterioration rate with observation alone is particularly low, over both a 6-month and 2-year period, suggesting that observation alone is a very reasonable option. Future studies on the natural history of childhood intermittent exotropia are forthcoming and a larger randomized clinical trial of over-minus spectacles versus non-over-minus spectacles is planned.